Literature DB >> 14963716

Ocular symptoms and signs in patients with ectodermal dysplasia syndromes.

T Kaercher1.   

Abstract

PURPOSE: The ectodermal dysplasia syndromes are underestimated although precise inclusion criteria have been formulated. The purpose is to establish easily detectable ophthalmologic symptoms and signs as reliable criteria for ectodermal dysplasia syndromes.
METHODS: Thirty-six patients with confirmed ectodermal dysplasia syndromes were included in an observational case series: hypohidrotic ectodermal dysplasia (30), EEC syndrome (3), AEC syndrome (2), Gorlin-Goltz syndrome (1). Each patient was examined ophthalmologically. The principal outcome measures were ocular symptoms and signs in patients with different ectodermal dysplasia syndromes of varying severity.
METHODS: Some 94.4% of the patients suffered from dry eye symptoms. Reduction of eyebrows was seen in 94.4%; the lashes were altered in 91.6%. Changes of the meibomian glands were detected in 95.45%. Corneal changes such as pannus occurred later in life.
CONCLUSIONS: Alterations of the meibomian glands, which were detected by meibomianoscopy, are the most reliable ocular sign of ectodermal dysplasia syndromes.

Entities:  

Mesh:

Year:  2004        PMID: 14963716     DOI: 10.1007/s00417-004-0868-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  14 in total

1.  EEC syndrome (ectrodactyly, ectodermal dysplasia and cleft lip/palate) is on 7p11.2-q21.3.

Authors:  M B Qumsiyeh
Journal:  Clin Genet       Date:  1992-08       Impact factor: 4.438

Review 2.  Hypohidrotic ectodermal dysplasia.

Authors:  A Clarke
Journal:  J Med Genet       Date:  1987-11       Impact factor: 6.318

3.  The Tabby phenotype is caused by mutation in a mouse homologue of the EDA gene that reveals novel mouse and human exons and encodes a protein (ectodysplasin-A) with collagenous domains.

Authors:  A K Srivastava; J Pispa; A J Hartung; Y Du; S Ezer; T Jenks; T Shimada; M Pekkanen; M L Mikkola; M S Ko; I Thesleff; J Kere; D Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  The breakpoints of the EEC syndrome (ectrodactyly, ectodermal dysplasia and cleft lip/palate) confirmed to 7q11.21 and 9p12 by fluorescence in situ hybridization.

Authors:  Y Fukushima; H Ohashi; T Hasegawa
Journal:  Clin Genet       Date:  1993-07       Impact factor: 4.438

5.  Ocular manifestations in a father and son with EEC syndrome.

Authors:  B Käsmann; K W Ruprecht
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-08       Impact factor: 3.117

6.  In vivo transillumination biomicroscopy and photography of meibomian gland dysfunction. A clinical study.

Authors:  J B Robin; J V Jester; J Nobe; N Nicolaides; R E Smith
Journal:  Ophthalmology       Date:  1985-10       Impact factor: 12.079

7.  Induction of sweat glands by epidermal growth factor in murine X-linked anhidrotic ectodermal dysplasia.

Authors:  S R Blecher; J Kapalanga; D Lalonde
Journal:  Nature       Date:  1990-06-07       Impact factor: 49.962

8.  Absent meibomian glands in the ectrodactyly, ectodermal dysplasia, cleft lip-palate syndrome.

Authors:  B J Mondino; P E Bath; R Y Foos; L Apt; G M Rajacich
Journal:  Am J Ophthalmol       Date:  1984-04       Impact factor: 5.258

Review 9.  [Ocular involvement in ectodermal dysplasia].

Authors:  G Koniszewski; M Maywald; V Henke
Journal:  Klin Monbl Augenheilkd       Date:  1987-06       Impact factor: 0.700

10.  The effect of various intakes of omega 3 fatty acids on the blood lipid composition in healthy human subjects.

Authors:  H C Bronsgeest-Schoute; C M van Gent; J B Luten; A Ruiter
Journal:  Am J Clin Nutr       Date:  1981-09       Impact factor: 7.045

View more
  23 in total

Review 1.  EDA signaling and skin appendage development.

Authors:  Chang-Yi Cui; David Schlessinger
Journal:  Cell Cycle       Date:  2006-09-14       Impact factor: 4.534

Review 2.  The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD.

Authors:  Debra A Schaumberg; Jason J Nichols; Eric B Papas; Louis Tong; Miki Uchino; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

3.  Meibomian gland morphogenesis requires developmental eyelid closure and lid fusion.

Authors:  Jingjing Wang; Mindy Call; Maureen Mongan; Winston Whei-Yang Kao; Ying Xia
Journal:  Ocul Surf       Date:  2017-03-08       Impact factor: 5.033

4.  Ocular and non-ocular manifestations of hypohidrotic ectodermal dysplasia.

Authors:  Pallavi Tyagi; Vipin Tyagi; Adnan A Hashim
Journal:  BMJ Case Rep       Date:  2011-04-01

5.  Mutational spectrum in 101 patients with hypohidrotic ectodermal dysplasia and breakpoint mapping in independent cases of rare genomic rearrangements.

Authors:  Sigrun Wohlfart; Johanna Hammersen; Holm Schneider
Journal:  J Hum Genet       Date:  2016-06-16       Impact factor: 3.172

6.  Ectodysplasin A protein promotes corneal epithelial cell proliferation.

Authors:  Sanming Li; Jing Zhou; Jinghua Bu; Ke Ning; Liying Zhang; Juan Li; Yuli Guo; Xin He; Hui He; Xiaoxin Cai; Yongxiong Chen; Peter Sol Reinach; Zuguo Liu; Wei Li
Journal:  J Biol Chem       Date:  2017-06-27       Impact factor: 5.157

Review 7.  [Blepharitis].

Authors:  T Kaercher; H Brewitt
Journal:  Ophthalmologe       Date:  2004-11       Impact factor: 1.059

8.  [Meibomian glands : part III. Dysfunction - argument for a discrete disease entity and as an important cause of dry eye].

Authors:  E Knop; N Knop; H Brewitt; U Pleyer; P Rieck; B Seitz; F Schirra
Journal:  Ophthalmologe       Date:  2009-11       Impact factor: 1.059

9.  Early respiratory and ocular involvement in X-linked hypohidrotic ectodermal dysplasia.

Authors:  Jasna Dietz; Thomas Kaercher; Anne-Theres Schneider; Theodor Zimmermann; Kenneth Huttner; Ramsey Johnson; Holm Schneider
Journal:  Eur J Pediatr       Date:  2013-04-04       Impact factor: 3.183

10.  Enhanced Edar signalling has pleiotropic effects on craniofacial and cutaneous glands.

Authors:  Shie Hong Chang; Stephanie Jobling; Keith Brennan; Denis J Headon
Journal:  PLoS One       Date:  2009-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.